Table 2.

Prevalence of metabolic syndrome and its components in patients with bipolar disorder

Author/Country	Criteria	MetS	WC	↓HDL	↑TG	↑Glucose	↑BP
Fagiolini et al., 2005, USA [22]	ATP III	30%	49%	23%	48%	8%	39%
Yumru et al., 2007, Turkey [23]	ATP III	32%	_	_	_	_	_
Birkenaes et al., 2006, Norway [24]	ATP III	30% (male)	_	_	_	_	_
		17% (female)
Garcia‐Portilla et al., 2007, Spain [25]	ATP III	22.4%	54%	38.2%	36.1%	12.2%	20.9%
Teixeira et al, 2007, Brazil [26]	ATP III	38.3%	_	_	_	_	_
Salvi et al., 2008, Italy [27]	ATP III	25.3%	50%	32.3%	34.7%	11%	40%
	IDF	30%
Fagiolini et al., 2008, USA [28]	ATP III	40%	51%	45%	47%	19%	55%
Cardenas et al., 2008, USA [29]	ATP III	49%	_	_	_	_	_
Van Winkel et al.,2008, Belgium [30]	ATP III	16.7%	30%	21.7%	26.7%	13.3%	48.3%
	ATP III + FG ≥ 100	18.3%				28.3%
	IDF	30%	60%			28.3%
Fiedorowicz et al., 2008, USA [31]	ATP III	53%	_	27%	48%	28%	63%
Correll et al., 2008, USA [32]	ATP III	43.2%	33.8%	67.6%	46.6%	32.4%	54%
	ATP III + FG ≥ 100	54%
Sicras et al., 2008, Spain [33]	ATP III	24.7%	_	54.5%	23%	16.9%	29.8%
Yumru et al., 2008, Turkey [34]	ATP III	36.7%	_	_	_	_	_
Almeida et al., 2009, Brazil [35]	ATP III/AHA	28.6%	46.4%	26.2%	44%	20.2%	45.2%
Vuksan‐Cusa et al., 2009, Croatia [36]	ATP III	27.5%	_	_	_	_	_
Chang et al., 2009, Taiwan [37]	IDF	33.9%	61%	53%	36.8%	13.7%	18.6%
Lee et al., 2010, South Korea [38]	AHA (FG ≥ 100)	27%				5.3%
	ATP III	25%	47.4%	32.9%	32.9%	15.1%	25.7%
	IDF	25.7%				5.3%
Kemp et al., 2010, USA [39]	ATP III	36%	_	_	_	_	_

ATP III, Adult Treatment Panel III; IDF, International Diabetes Foundation; AHA/NHLBI, American Heart Association/National Heart, Lung, and Blood Institute.

FG, fasting glucose; BP, blood pressure; WC, waist circumference; TG, triglycerides; HDL, high‐density lipoprotein cholesterol.